Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
8.07
+0.21 (2.67%)
At close: Aug 28, 2025, 4:00 PM
8.11
+0.04 (0.50%)
Pre-market: Aug 29, 2025, 5:14 AM EDT

Kura Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
7006771,0688479322,157
Upgrade
Market Cap Growth
-68.15%-36.58%26.07%-9.08%-56.80%246.13%
Upgrade
Enterprise Value
892396334253961,847
Upgrade
Last Close Price
8.078.7114.3812.4114.0032.66
Upgrade
PS Ratio
8.4612.57----
Upgrade
PB Ratio
2.291.642.692.021.843.53
Upgrade
P/TBV Ratio
2.291.642.692.021.843.53
Upgrade
P/FCF Ratio
5.705.06----
Upgrade
P/OCF Ratio
5.605.04----
Upgrade
EV/Sales Ratio
1.074.43----
Upgrade
EV/FCF Ratio
0.731.78----
Upgrade
Debt / Equity Ratio
0.060.040.040.030.010.03
Upgrade
Debt / FCF Ratio
0.160.12----
Upgrade
Asset Turnover
0.140.09----
Upgrade
Quick Ratio
5.939.3212.0518.2423.1324.34
Upgrade
Current Ratio
6.169.4612.2618.5623.2624.49
Upgrade
Return on Equity (ROE)
-51.11%-42.91%-37.34%-29.31%-23.35%-21.60%
Upgrade
Return on Assets (ROA)
-22.93%-19.97%-22.89%-17.65%-13.89%-12.92%
Upgrade
Return on Capital (ROIC)
-34.00%-28.59%-24.42%-18.45%-14.40%-13.48%
Upgrade
Earnings Yield
-28.15%-25.69%-14.29%-16.04%-14.00%-4.16%
Upgrade
FCF Yield
17.54%19.76%-11.70%-13.07%-11.34%-3.34%
Upgrade
Buyback Yield / Dilution
-7.33%-17.66%-9.31%-0.96%-25.01%-26.54%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q